Domestic Substitution Accelerates, Surgical Robot Industry Enters Harvesting Phase

As the global medical equipment industry undergoes intelligent transformation, the surgical robot track is experiencing a double resonance of explosion in installed capacity and policy dividends. The latest data shows that domestic laparoscopic surgical robots, with technological breakthroughs and price advantages, are accelerating the break of monopoly in the domestic market and entering the global market with an unprecedented posture.

Domestic substitution is orderly promoted, domestic brands set sail

By 2025, the installation pattern of Chinese surgical robots has changed significantly. The "Da Vinci" surgical robot, which has long dominated, has reduced its share of installations to 42%, while domestic leading brands **Jingfeng Medical, Micro-Robotics** have reached 20% and 16% respectively, and domestic substitution is presenting an orderly trend.

While based in China, the pace of domestic manufacturers going abroad has also greatly accelerated. So far, Jingfeng Medical and Micro-Robotics have globally signed 92 and over 100 units respectively. The rapid increase in overseas installations has not only driven the expansion of revenue scale but also further optimized the global revenue structure of enterprises, enhancing international competitiveness.

Policy continues to add code, business model increasingly improved

In the "14th Five-Year Plan" equipment certificate plan, surgical robots are clearly categorized as Class B, with an additional allocation of more than 550 units. With the expectation of the "15th Five-Year Plan" approaching, the industry entry threshold is expected to further lower, creating a broader space for product promotion.

Entering 2026, the implementation of medical insurance and charging policies has become the focus of industry attention. In January, the National Health Insurance Bureau issued related guidelines, clarifying the important position of surgical robot systems and consumables in the clinical end.

In April, Hunan Province took the lead in publicizing the key points of auxiliary charging, establishing four levels of operation, pricing methods, and cap prices, making product charging truly based on evidence.

Analysis believes that the dense landing of policies marks that the long-term business model of surgical robots has gradually entered a mature stage.

Benchmarking global leaders, regular income becomes the core of growth

As an industry benchmark, the financial performance of Intuitive Surgery provides a clear logic reference for the market. As of April 23, 2026, the company's market value has exceeded 170 billion US dollars, with a global cumulative installation of more than 11,000 units and a cumulative operation volume of more than 20 million.

It is worth noting the change in its revenue structure. Intuitive Surgery's regular income (consumables and services) has increased from 45% in 2006 to 84% in 2025. This business logic of shifting from "equipment sales dominance" to "flow income" has been highly recognized by the market.

With the steady growth of installed capacity, the future surgical robot industry will achieve more robust long-term growth through high-frequency surgical consumables and professional services.